BIO-key International, Inc.

BIO-key International, Inc.'s next confirmed earnings release is scheduled for November 16, 2026.

As of June 30, 2026, BIO-key International, Inc. has 1.09M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 0.62, and the price-to-book ratio stands at 1.13.

These figures are as of June 30, 2026. The EV/Sales ratio of 0.65 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative.

As of June 30, 2026, BIO-key International, Inc. maintains a current ratio of 1.26, meaning it holds 1.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 19.88, indicating elevated leverage, while an interest coverage ratio of -55.54 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, BIO-key International, Inc. posted a negative return on equity (ROE) of -107.91, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -67.07, reflecting losses generated across the asset base. Inventory turnover of 3.61 indicates how many times BIO-key International, Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

As of the close on October 22, 2026, BIO-key International, Inc.'s stock has declined approximately 63.53% over the past 52 weeks. The 50-day moving average sits at 2.61, while the 200-day moving average is 5.02.

Over the twelve months ended June 30, 2026, BIO-key International, Inc. posted a gross margin of 81.32, reflecting its pricing power and cost economics. The operating margin of -49.12 and net profit margin of -90.10 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -99.72: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -69.09, meaning BIO-key International, Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

BIO-key International, Inc.'s most recent stock split took place on April 30, 2026 with a 10:1 split ratio.

As of June 30, 2026, BIO-key International, Inc. has an Altman Z-Score of -27.94, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.